Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moreau

Showing results (331-340 of 343) with videos related to

Pageof 35
Sort By:
Alimentary Pharmacology & Therapeutics|June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort studyA Amiot, M Serrero, L Peyrin-Biroulet, et al.
Journal of Medicinal Chemistry|March 20, 2018
Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial ActivityColin K Skepper, Robert J Moreau, Brent A Appleton, et al.
Rheumatology (Oxford, England)|May 15, 2025
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacySaskia R Veldkamp, Maud Reugebrink, Sanne W Evers, et al.
American Journal of Human Genetics|January 24, 2004
Mutations within the MGC4607 gene cause cerebral cavernous malformationsC Denier, S Goutagny, P Labauge, et al.
Journal of Medicinal Chemistry|March 3, 2018
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative BacteriaRobert J Moreau, Colin K Skepper, Brent A Appleton, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
The Journal of Allergy and Clinical Immunology|July 28, 2023
Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotypeAntoine Fayand, Margaux Cescato, Laurent Le Corre, et al.
Rheumatology (Oxford, England)|October 17, 2025
IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodiesThomas R J Moreau, Vincent Bondet, Saskia R Veldkamp, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2023
Successful treatment of JAK1-associated inflammatory diseaseAntoine Fayand, Véronique Hentgen, Céline Posseme, et al.
Applied Optics|May 22, 2007
Measurement of the optical parameters of the Virgo interferometer, Fausto Acernese, Mohamed Alshourbagy, et al.
Pageof 35

Showing results (331-340 of 343) with videos related to

Sort By:
Pageof 35
Alimentary Pharmacology & Therapeutics|June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort studyA Amiot, M Serrero, L Peyrin-Biroulet, et al.
Journal of Medicinal Chemistry|March 20, 2018
Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial ActivityColin K Skepper, Robert J Moreau, Brent A Appleton, et al.
Rheumatology (Oxford, England)|May 15, 2025
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacySaskia R Veldkamp, Maud Reugebrink, Sanne W Evers, et al.
American Journal of Human Genetics|January 24, 2004
Mutations within the MGC4607 gene cause cerebral cavernous malformationsC Denier, S Goutagny, P Labauge, et al.
Journal of Medicinal Chemistry|March 3, 2018
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative BacteriaRobert J Moreau, Colin K Skepper, Brent A Appleton, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
The Journal of Allergy and Clinical Immunology|July 28, 2023
Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotypeAntoine Fayand, Margaux Cescato, Laurent Le Corre, et al.
Rheumatology (Oxford, England)|October 17, 2025
IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodiesThomas R J Moreau, Vincent Bondet, Saskia R Veldkamp, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2023
Successful treatment of JAK1-associated inflammatory diseaseAntoine Fayand, Véronique Hentgen, Céline Posseme, et al.
Applied Optics|May 22, 2007
Measurement of the optical parameters of the Virgo interferometer, Fausto Acernese, Mohamed Alshourbagy, et al.
Pageof 35